Articles
Patient perspectives: Kerri Morrone Sparling

Patient perspectives: Kerri Morrone Sparling

Continuing our patient perspectives series, pharmaphorum talks to Kerri Morrone Sparling about her experience as a patient with diabetes. With all chronic illnesses, psycho-social support is essential, and diabetes is no exception. Aside from the difficulties associated with...

Articles
Time to Evolve! Overview of eyeforpharma’s ‘7th annual e-marketing Europe and mobile 2012’ event

Time to Evolve! Overview of eyeforpharma’s ‘7th annual e-mar...

Ángel González provides an overview of the topics addressed at eyeforpharma’s recent ‘7th annual e-marketing Europe and mobile 2012’ event. Time to evolve - this was the claim used by the organization as the forefront message of this international event.

Articles
Beyond clinician support: how to successfully launch paradigm-shifting technologies

Beyond clinician support: how to successfully launch paradig...

David Lee and Peter Ehrhardt explore the factors medical technology manufacturers face when pricing paradigm-shifting technologies, looking at past pharma product launches for insights into the current process. Paradigm-shifting technologies, defined as innovations that change the standard of care in a significant way, are the lifeblood of the medical technology industry…

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more